225 related articles for article (PubMed ID: 27845275)
1. A hybrid siRNA delivery complex for enhanced brain penetration and precise amyloid plaque targeting in Alzheimer's disease mice.
Zheng X; Pang X; Yang P; Wan X; Wei Y; Guo Q; Zhang Q; Jiang X
Acta Biomater; 2017 Feb; 49():388-401. PubMed ID: 27845275
[TBL] [Abstract][Full Text] [Related]
2. Dual-functional nanoparticles targeting amyloid plaques in the brains of Alzheimer's disease mice.
Zhang C; Wan X; Zheng X; Shao X; Liu Q; Zhang Q; Qian Y
Biomaterials; 2014 Jan; 35(1):456-65. PubMed ID: 24099709
[TBL] [Abstract][Full Text] [Related]
3. Enhanced BBB permeability of osmotically active poly(mannitol-co-PEI) modified with rabies virus glycoprotein via selective stimulation of caveolar endocytosis for RNAi therapeutics in Alzheimer's disease.
Park TE; Singh B; Li H; Lee JY; Kang SK; Choi YJ; Cho CS
Biomaterials; 2015 Jan; 38():61-71. PubMed ID: 25457984
[TBL] [Abstract][Full Text] [Related]
4. A designed recombinant fusion protein for targeted delivery of siRNA to the mouse brain.
Haroon MM; Dar GH; Jeyalakshmi D; Venkatraman U; Saba K; Rangaraj N; Patel AB; Gopal V
J Control Release; 2016 Apr; 228():120-131. PubMed ID: 26948382
[TBL] [Abstract][Full Text] [Related]
5. Design and chemical synthesis of a magnetic resonance contrast agent with enhanced in vitro binding, high blood-brain barrier permeability, and in vivo targeting to Alzheimer's disease amyloid plaques.
Poduslo JF; Curran GL; Peterson JA; McCormick DJ; Fauq AH; Khan MA; Wengenack TM
Biochemistry; 2004 May; 43(20):6064-75. PubMed ID: 15147190
[TBL] [Abstract][Full Text] [Related]
6. Detection of amyloid plaques targeted by bifunctional USPIO in Alzheimer's disease transgenic mice using magnetic resonance microimaging.
Wadghiri YZ; Li J; Wang J; Hoang DM; Sun Y; Xu H; Tsui W; Li Y; Boutajangout A; Wang A; de Leon M; Wisniewski T
PLoS One; 2013; 8(2):e57097. PubMed ID: 23468919
[TBL] [Abstract][Full Text] [Related]
7. Brain-targeted co-delivery of therapeutic gene and peptide by multifunctional nanoparticles in Alzheimer's disease mice.
Liu Y; An S; Li J; Kuang Y; He X; Guo Y; Ma H; Zhang Y; Ji B; Jiang C
Biomaterials; 2016 Feb; 80():33-45. PubMed ID: 26706474
[TBL] [Abstract][Full Text] [Related]
8. Quinoline-n-butylcyanoacrylate-based nanoparticles for brain targeting for the diagnosis of Alzheimer's disease.
Kulkarni PV; Roney CA; Antich PP; Bonte FJ; Raghu AV; Aminabhavi TM
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2010; 2(1):35-47. PubMed ID: 20049829
[TBL] [Abstract][Full Text] [Related]
9. Analysis of focused ultrasound-induced blood-brain barrier permeability in a mouse model of Alzheimer's disease using two-photon microscopy.
Burgess A; Nhan T; Moffatt C; Klibanov AL; Hynynen K
J Control Release; 2014 Oct; 192():243-8. PubMed ID: 25107692
[TBL] [Abstract][Full Text] [Related]
10. PEGylated poly(2-(dimethylamino) ethyl methacrylate)/DNA polyplex micelles decorated with phage-displayed TGN peptide for brain-targeted gene delivery.
Qian Y; Zha Y; Feng B; Pang Z; Zhang B; Sun X; Ren J; Zhang C; Shao X; Zhang Q; Jiang X
Biomaterials; 2013 Mar; 34(8):2117-29. PubMed ID: 23245924
[TBL] [Abstract][Full Text] [Related]
11. Molecular targeting of Alzheimer's amyloid plaques for contrast-enhanced magnetic resonance imaging.
Poduslo JF; Wengenack TM; Curran GL; Wisniewski T; Sigurdsson EM; Macura SI; Borowski BJ; Jack CR
Neurobiol Dis; 2002 Nov; 11(2):315-29. PubMed ID: 12505424
[TBL] [Abstract][Full Text] [Related]
12. Design and evaluation of a 6-mer amyloid-beta protein derived phage display library for molecular targeting of amyloid plaques in Alzheimer's disease: Comparison with two cyclic heptapeptides derived from a randomized phage display library.
Larbanoix L; Burtea C; Ansciaux E; Laurent S; Mahieu I; Vander Elst L; Muller RN
Peptides; 2011 Jun; 32(6):1232-43. PubMed ID: 21575663
[TBL] [Abstract][Full Text] [Related]
13. Amyloid-β plaque reduction, endogenous antibody delivery and glial activation by brain-targeted, transcranial focused ultrasound.
Jordão JF; Thévenot E; Markham-Coultes K; Scarcelli T; Weng YQ; Xhima K; O'Reilly M; Huang Y; McLaurin J; Hynynen K; Aubert I
Exp Neurol; 2013 Oct; 248():16-29. PubMed ID: 23707300
[TBL] [Abstract][Full Text] [Related]
14. β-Amyloid targeting nanodrug for neuron-specific delivery of nucleic acids in Alzheimer's disease mouse models.
Israel LL; Sun T; Braubach O; Cox A; Shatalova ES; Rashid HM; Galstyan A; Grodzinski Z; Song XY; Chepurna O; Ljubimov VA; Chiechi A; Sharma S; Phebus C; Wang Y; Ljubimova JY; Black KL; Holler E
J Control Release; 2023 Sep; 361():636-658. PubMed ID: 37544515
[TBL] [Abstract][Full Text] [Related]
15. GM1-Modified Lipoprotein-like Nanoparticle: Multifunctional Nanoplatform for the Combination Therapy of Alzheimer's Disease.
Huang M; Hu M; Song Q; Song H; Huang J; Gu X; Wang X; Chen J; Kang T; Feng X; Jiang D; Zheng G; Chen H; Gao X
ACS Nano; 2015 Nov; 9(11):10801-16. PubMed ID: 26440073
[TBL] [Abstract][Full Text] [Related]
16. Sialic acid (SA)-modified selenium nanoparticles coated with a high blood-brain barrier permeability peptide-B6 peptide for potential use in Alzheimer's disease.
Yin T; Yang L; Liu Y; Zhou X; Sun J; Liu J
Acta Biomater; 2015 Oct; 25():172-83. PubMed ID: 26143603
[TBL] [Abstract][Full Text] [Related]
17. Binding of two potential imaging agents targeting amyloid plaques in postmortem brain tissues of patients with Alzheimer's disease.
Kung MP; Hou C; Zhuang ZP; Skovronsky D; Kung HF
Brain Res; 2004 Oct; 1025(1-2):98-105. PubMed ID: 15464749
[TBL] [Abstract][Full Text] [Related]
18. Enhanced glutathione PEGylated liposomal brain delivery of an anti-amyloid single domain antibody fragment in a mouse model for Alzheimer's disease.
Rotman M; Welling MM; Bunschoten A; de Backer ME; Rip J; Nabuurs RJ; Gaillard PJ; van Buchem MA; van der Maarel SM; van der Weerd L
J Control Release; 2015 Apr; 203():40-50. PubMed ID: 25668771
[TBL] [Abstract][Full Text] [Related]
19. Systemic peptide mediated delivery of an siRNA targeting α-syn in the CNS ameliorates the neurodegenerative process in a transgenic model of Lewy body disease.
Spencer B; Trinh I; Rockenstein E; Mante M; Florio J; Adame A; El-Agnaf OMA; Kim C; Masliah E; Rissman RA
Neurobiol Dis; 2019 Jul; 127():163-177. PubMed ID: 30849508
[TBL] [Abstract][Full Text] [Related]
20. Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes.
Alvarez-Erviti L; Seow Y; Yin H; Betts C; Lakhal S; Wood MJ
Nat Biotechnol; 2011 Apr; 29(4):341-5. PubMed ID: 21423189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
